Delphi-Based Consensus on Treatment Intensification in Type 2 Diabetes Subjects Failing Basal Insulin Supported Oral Treatment: Focus on Basal Insulin + GLP-1 Receptor Agonist Combination Therapies.

Gian Poalo FadiniOlga DisoteoRiccardo CandidoPaolo Di BartoloLuigi LaviolaAgostino Consoli

Published in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2021)

According to this Delphi consensus, the addition of a GLP-1RA may be the best option to intensify BOT. The BI/GLP-1RA fixed combinations may increase compliance and optimize the advantages of each of these molecules.

Keyphrases

type diabetes
glycemic control
rheumatoid arthritis
cardiovascular disease
disease activity
metabolic syndrome
systemic sclerosis
combination therapy
skeletal muscle
ankylosing spondylitis
adipose tissue